Cannabinoids in late life parkinson’s disease and dementia: biological pathways and clinical challenges

HIGHLIGHTS

  • who: Alana C. Costa and colleagues from the Laboratory of Neuroscience (LIM-27), Departamento e Instituto Psiquiatria, Hospital das Clu00ednicas, Universidade Su00e3o Paulo, Su00e3o Paulo, Brazil have published the paper: Cannabinoids in Late Life Parkinsonu2019s Disease and Dementia: Biological Pathways and Clinical Challenges, in the Journal: (JOURNAL)
  • what: In this review the authors aimed to address preclinical evidence of cannabinoids in neurodegenerative disorders such as PD and AD and discuss potential off-label use of cannabinoids in clinical practice of these disorders. published maps and institutional affiliations. The main reason sustaining this argument is the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?